Chemical inhibitors of C5orf5 include a range of molecules that interfere with various signaling pathways and cellular processes that are crucial for the protein's function. Staurosporine and Bisindolylmaleimide I serve as protein kinase inhibitors, targeting the phosphorylation events that are essential for C5orf5 activation. By blocking these kinases, these inhibitors prevent the phosphorylation-dependent activation of C5orf5, hindering its ability to participate in downstream signaling. Similarly, LY294002 and Wortmannin exert their effects by inhibiting phosphoinositide 3-kinases (PI3K), which play a pivotal role in the PI3K/Akt pathway, a crucial signaling route for cell survival and proliferation. The inhibition of PI3K disrupts this pathway, which can lead to the suppression of C5orf5 activities related to these cellular processes.
Additionally, PD98059 and U0126 specifically target MEK, an upstream kinase in the MAPK/ERK pathway. The inhibition of MEK by these chemicals would lead to reduced activation of ERK and subsequent signaling cascades, which may include C5orf5. This results in a blockade of the pathway's influence on C5orf5, leading to its functional inhibition. SP600125 prevents JNK activation, which may be necessary for C5orf5's role in JNK-mediated cellular responses. Rapamycin, a well-known inhibitor of the mTOR pathway, can suppress C5orf5 if it is part of the mTOR-regulated signaling processes. Y-27632 targets the Rho-associated protein kinase (ROCK), inhibition of which can alter cell shape and motility, processes that may require C5orf5 activity. SB431542 disrupts TGF-beta signaling, which could lead to the inhibition of C5orf5 if it is implicated in this pathway. Alsterpaullone's inhibition of cyclin-dependent kinases may also affect C5orf5 by disrupting cell cycle control mechanisms in which the protein might be involved. Finally, ZM-447439 inhibits Aurora kinases, and through this action, it can inhibit C5orf5 if its functions are related to mitotic events regulated by these kinases. Each of these chemicals targets specific kinases or pathways that are essential for the proper functioning of C5orf5, thereby leading to its inhibition.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Inhibits protein kinases that C5orf5 may rely on for phosphorylation, thereby inhibiting C5orf5 activity. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Inhibits protein kinase C which may be essential for C5orf5 activation through phosphorylation. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Inhibits PI3K, potentially disrupting the PI3K/Akt pathway and thus inhibiting C5orf5 activity in cell survival and proliferation. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Inhibits PI3K like LY294002, thereby possibly hindering C5orf5 functions related to the PI3K/Akt pathway. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
Inhibits MEK, which may be upstream of C5orf5 in the MAPK/ERK pathway, leading to its inhibition. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
Another MEK inhibitor, which may prevent activation of C5orf5 if it is involved in the MAPK/ERK pathway. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, potentially inhibiting C5orf5 activity if it is involved in JNK-mediated signaling responses. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits mTOR signaling, which could inhibit C5orf5 if it is involved in pathways regulated by mTOR. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Inhibits ROCK, which might be necessary for C5orf5's function in cell shape and motility regulation. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $82.00 $216.00 $416.00 | 48 | |
Inhibits TGF-beta signaling, possibly leading to the inhibition of C5orf5 if it is part of this pathway. | ||||||